News

A growing number of consumers taking expensive drugs are discovering they are no longer insulated by copay assistance programs.

Hospitals will be tasked to perform fewer unnecessary cesarean sections, prescribe fewer opioids and cut back on the use of imaging to diagnose and treat back pain.

Unlike traditional drugs, gene therapies are intended to be given once, transform the inner workings of the body and last for a lifetime.

After a $14,000 price tag for its cholesterol fighter Repatha proved more than insurers were willing to pay, the company is taking a more conservative approach with its latest blockbuster.

BRS regulations include mandatory education for servicemembers before they make the choice, but spouses are not included.

Initiatives to boost hiring of military spouses—who otherwise can find it tough to get a job—are finding traction among several companies.